TY  - GEN
AU  - Augustin,M
AU  - Thaci,D
AU  - Eyerich,K
AU  - Pinter,A
AU  - Radtke,M
AU  - Lauffer,F
AU  - Mrowietz,U
AU  - Gerdes,S
AU  - Pariser,D
AU  - Lebwohl,M
AU  - Sieder,C
AU  - Melzer,N
AU  - Reich,K
TI  - Continued treatment with secukinumab is associated with high retention or regain of response
SN  - 1365-2133
PY  - 2021///0514
KW  - Antibodies, Monoclonal, Humanized
KW  - Etanercept
KW  - Humans
KW  - Psoriasis
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Severity of Illness Index
KW  - Treatment Outcome
KW  - Ustekinumab
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/bjd.17991
ER  -